OBJECTIVES: To evaluate the prevalence of metabolic syndrome (MetS) and its association with physical capacity, disability, and self-rated health in older adults at high risk of mobility disability, including those with and without diabetes mellitus. DESIGN: Cross-sectional analysis. SETTING: Lifestyle Interventions and Independence for Elders (LIFE) Study. PARTICIPANTS: Community-dwelling sedentary adults aged 70 to 89 at high risk of mobility disability (Short Physical Performance Battery (SPPB) score ≤9; mean 7.4 ± 1.6) (N = 1,535). MEASUREMENTS: Metabolic syndrome was defined according to the 2009 multiagency harmonized criteria; outcomes were physical capacity (400-m walk time, grip strength, SPPB score), disability (composite 19-item score), and self-rated health (5-point scale ranging from excellent to poor). RESULTS: The prevalence of MetS was 49.8% in the overall sample (83.2% of those with diabetes mellitus, 38.1% of those without). MetS was associated with stronger grip strength (mean difference (Δ) = 1.2 kg, P = .01) in the overall sample and in participants without diabetes mellitus and with poorer self-rated health (Δ = 0.1 kg, P < .001) in the overall sample only. No significant differences were found in 400-m walk time, SPPB score, or disability score between participants with and without MetS, in the overall sample or diabetes mellitus subgroups. CONCLUSION:Metabolic dysfunction is highly prevalent in older adults at risk of mobility disability, yet consistent associations were not observed between MetS and walking speed, lower extremity function, or self-reported disability after adjusting for known and potential confounders. Longitudinal studies are needed to investigate whether MetS accelerates declines in functional status in high-risk older adults and to inform clinical and public health interventions aimed at preventing or delaying disability in this group.
RCT Entities:
OBJECTIVES: To evaluate the prevalence of metabolic syndrome (MetS) and its association with physical capacity, disability, and self-rated health in older adults at high risk of mobility disability, including those with and without diabetes mellitus. DESIGN: Cross-sectional analysis. SETTING: Lifestyle Interventions and Independence for Elders (LIFE) Study. PARTICIPANTS: Community-dwelling sedentary adults aged 70 to 89 at high risk of mobility disability (Short Physical Performance Battery (SPPB) score ≤9; mean 7.4 ± 1.6) (N = 1,535). MEASUREMENTS: Metabolic syndrome was defined according to the 2009 multiagency harmonized criteria; outcomes were physical capacity (400-m walk time, grip strength, SPPB score), disability (composite 19-item score), and self-rated health (5-point scale ranging from excellent to poor). RESULTS: The prevalence of MetS was 49.8% in the overall sample (83.2% of those with diabetes mellitus, 38.1% of those without). MetS was associated with stronger grip strength (mean difference (Δ) = 1.2 kg, P = .01) in the overall sample and in participants without diabetes mellitus and with poorer self-rated health (Δ = 0.1 kg, P < .001) in the overall sample only. No significant differences were found in 400-m walk time, SPPB score, or disability score between participants with and without MetS, in the overall sample or diabetes mellitus subgroups. CONCLUSION:Metabolic dysfunction is highly prevalent in older adults at risk of mobility disability, yet consistent associations were not observed between MetS and walking speed, lower extremity function, or self-reported disability after adjusting for known and potential confounders. Longitudinal studies are needed to investigate whether MetS accelerates declines in functional status in high-risk older adults and to inform clinical and public health interventions aimed at preventing or delaying disability in this group.
Authors: J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace Journal: J Gerontol A Biol Sci Med Sci Date: 2000-04 Impact factor: 6.053
Authors: Erik J Groessl; Robert M Kaplan; W Jack Rejeski; Jeffrey A Katula; Abby C King; Georita Frierson; Nancy W Glynn; Fang-Chi Hsu; Michael Walkup; Marco Pahor Journal: Am J Prev Med Date: 2007-09 Impact factor: 5.043
Authors: Susan A Everson-Rose; Misti Paudel; Brent C Taylor; Tien Dam; Peggy Mannen Cawthon; Erin Leblanc; Elsa S Strotmeyer; Jane A Cauley; Marcia L Stefanick; Elizabeth Barrett-Connor; Kristine E Ensrud Journal: J Am Geriatr Soc Date: 2011-08-01 Impact factor: 5.562
Authors: Anne Shumway-Cook; Jack M Guralnik; Caroline L Phillips; Antonia K Coppin; Marcia A Ciol; Stefania Bandinelli; Luigi Ferrucci Journal: J Am Geriatr Soc Date: 2007-01 Impact factor: 5.562
Authors: Roger A Fielding; W Jack Rejeski; Steven Blair; Tim Church; Mark A Espeland; Thomas M Gill; Jack M Guralnik; Fang-Chi Hsu; Jeffrey Katula; Abby C King; Stephen B Kritchevsky; Mary M McDermott; Michael E Miller; Susan Nayfield; Anne B Newman; Jeff D Williamson; Denise Bonds; Sergei Romashkan; Evan Hadley; Marco Pahor Journal: J Gerontol A Biol Sci Med Sci Date: 2011-08-08 Impact factor: 6.053
Authors: Catherine A Okoro; Yuna Zhong; Earl S Ford; Lina S Balluz; Tara W Strine; Ali H Mokdad Journal: BMC Public Health Date: 2006-11-14 Impact factor: 3.295
Authors: Lee M Margolis; Sarah J Lessard; Yassine Ezzyat; Roger A Fielding; Donato A Rivas Journal: J Gerontol A Biol Sci Med Sci Date: 2017-10-01 Impact factor: 6.053
Authors: Kathy D Wright; Laura Moore-Schiltz; Abdus Sattar; Richard Josephson; Shirley M Moore Journal: J Cardiovasc Nurs Date: 2018 May/Jun Impact factor: 2.083
Authors: Stephen B Kritchevsky; Laura Lovato; Elizabeth P Handing; Steven Blair; Anda Botoseneanu; Jack M Guralnik; Christine Liu; Abby King; Anthony P Marsh; Marco Pahor; W Jack Rejeski; Bonnie Spring; Todd Manini Journal: Obesity (Silver Spring) Date: 2017-07 Impact factor: 5.002